通过N6-甲基氨酸RNA修饰来操纵瘤免疫微环境
Xinyu Sun1,2, Huirong Wang1, Xi Pu2,3
1Department of Otorhinolaryngology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Cancer gene therapy
|June 4, 2024
概括
N6-甲基氨酸 (m6A) 修饰调节瘤微环境中的免疫细胞活性. 了解这些表观遗传变化为开发向癌症免疫疗法提供了新的途径.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- N6-甲基氨酸 (m6A) 是哺乳动物中最常见的mRNA表观遗传修饰.
- m6A的修改对于免疫细胞的发育和功能至关重要.
- 调节 m6A 调节物的失调会影响癌症的发展和免疫规避.
研究的目的:
- 为了提供一个全面的概述m6A修改在侵入性免疫细胞.
- 探索m6A在瘤微环境中的免疫调节中的作用.
- 要总结m6A表观遗传调节器如何影响抗瘤免疫反应.
主要方法:
- 文献综述和对m6A修饰现有研究的综合.
- 分析m6A对免疫细胞激活和侵入的影响.
- 在瘤免疫学背景下对m6A调节者的检查.
主要成果:
- m6A修饰的酶通过调节免疫细胞活性来影响瘤的进展.
- 瘤细胞中的m6A调节体会影响抗瘤免疫反应.
- m6A修饰在塑造瘤免疫微环境方面发挥着重要作用.
结论:
- m6A修饰是免疫细胞功能和瘤发育的关键参与者.
- 准m6A通路为新型癌症免疫疗法提供了一个有前途的战略.
- 对m6A的进一步研究对于推进癌症治疗至关重要.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514


